Evidence map›Paper›PMID 41387818›Full record

Trial reportBMC pregnancy and childbirth2025

Uterovesical tourniquet for conservative management of placenta accreta spectrum: a prospective cohort study in a low-resource setting.

Abdalla Mousa, Hassan M Gaafar, Mohamed Abdullah, Moutaz M Elsherbini, Mazen Abdel-Rasheed, Dana Rida, Ahmad Saysaneh, Sally L Collins, Ahmed Abdelbar

Registry-linked trialAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in BMC pregnancy and childbirth, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06185894 (Single-step Placenta Accreta Resective Technique Tourniqueted vs Absence, Conservative Uterine Surgery), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06185894 naunknown statusnot on this map

Single-step Placenta Accreta Resective Technique Tourniqueted vs Absence, Conservative Uterine Surgery (SPARTACUS) Study

TypeinterventionalSponsorCairo UniversityRan2023 to 2024Enrolled40ConditionsPlacenta AccretaArmsUterovesical tourniquet before uterine devascularization steps, Conventional conservative surgery
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Abdalla MousaDepartment of Obstetrics and Gynaecology, Faculty of Medicine, Kasr Alainy Hospital, Cairo University, Cairo, Egypt.
Hassan M GaafarDepartment of Obstetrics and Gynaecology, Faculty of Medicine, Kasr Alainy Hospital, Cairo University, Cairo, Egypt.
Mohamed AbdullahDepartment of Obstetrics and Gynaecology, Faculty of Medicine, Kasr Alainy Hospital, Cairo University, Cairo, Egypt.
Moutaz M ElsherbiniDepartment of Obstetrics and Gynaecology, Faculty of Medicine, Kasr Alainy Hospital, Cairo University, Cairo, Egypt.
Mazen Abdel-RasheedReproductive Health Research Department, National Research Centre, Cairo, Egypt.
Dana RidaDepartment of Radiology, Jordan University, Amman, Jordan.
Ahmad SaysanehSchool of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, Westminster Bridge Road, London, SE1 7EH, UK.
Sally L CollinsNuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, UK.
Ahmed AbdelbarDepartment of Obstetrics and Gynaecology, Faculty of Medicine, Kasr Alainy Hospital, Cairo University, Cairo, Egypt. ahmed.abdelbar1@nhs.net.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPlacenta accreta spectrum (PAS) is a condition affecting the placental detachment during labour and could be associated with life-threatening haemorrhage. We evaluated a novel uterovesical tourniquet technique to reduce blood loss during uterine sparing surgery.

methodsThis is a prospective cohort study that was conducted between 01/10/2023 and 01/04/2024, at Cairo University Hospital. Pregnant women with confirmed intra operative diagnosis of PAS were recruited to this study. The study included the application of a tourniquet around the lower part of the uterus and bladder before the delivery of the fetus to control blood loss during the operation. The primary outcomes were the operative procedure performed (Uterine sparing surgery Vs Caesarean Hysterectomy) and the measurement of the intraoperative blood loss.

resultsTwelve patients were included in this study. The average gestational age at deliver was 35.17 weeks ± 0.72. The uterine sparing surgery was successful in 11 out of the 12 patients (91.7%). The mean intraoperative blood loss was 950 mL ± 233.55 and the average operative time was 84.58 min ± 41.64. The mean number of packed RBCs units' transfused was 1.58 units ± 1.38. One bladder injury occurred.

conclusionThe uterovesical tourniquet may reduce haemorrhage in PAS, offering a feasible option for resource-limited settings.

trial registrationThis trial has been registered on clinicaltrials.gov with the identifier NCT06185894.

Indexed as

Blood Loss, SurgicalConservative TreatmentOrgan Sparing TreatmentsPlacenta AccretaTourniquetsAdultCesarean SectionEgyptFemaleHumansHysterectomyOperative TimePostpartum HemorrhagePregnancyProspective StudiesTreatment OutcomePlacenta Accreta SpectrumUterine sparing treatmentUterovesical Tourniquet

Identifiers

PMID41387818
PMCPMC12817792

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.